Press release
Oncology Biosimilars Market Size Projected To Reach $16.48 Billion By 2034 With A Cagr Of 16.8%
Oncology Biosimilars Market
What Is the Projected Growth of the Oncology Biosimilars Market?
The oncology biosimilars market has grown significantly in recent years. It will expand from $6.9 billion in 2024 to $8.85 billion in 2025, at a CAGR of 28.3%. This growth is attributed to the increasing prevalence of cancer, the expiration of patents for biologic cancer drugs, government support for biosimilars, growing investments in biosimilar development and production, and the expanding geographical reach of biosimilars.
The oncology biosimilars market is projected to grow rapidly, reaching $16.48 billion in 2029 with a CAGR of 16.8%, driven by an expanding biosimilar portfolio, patient-focused approaches, efforts to reduce healthcare costs, and developments in targeted therapies. Key trends include biobetters, biosimilar combinations for oncology, supportive care biosimilars, and real-world data utilization.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2821
What Are the Different Oncology Biosimilars Market Segments?
The oncology biosimilars market covered in this report is segmented -
1) By Drug Type: Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)
2) By Cancer Type: Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types
3) By Distribution Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Monoclonal Antibody: Rituximab Biosimilars, Trastuzumab Biosimilars, Bevacizumab Biosimilars, Pembrolizumab Biosimilars
2) By Immunomodulators: Thalidomide Biosimilars, Lenalidomide Biosimilars, Pomalidomide Biosimilars
3) By Hematopoietic Agents: Epoetin Biosimilars, Darbepoetin Biosimilars
4) By Granulocyte Colony-Stimulating Factor (G-CSF): Filgrastim Biosimilars, Pegfilgrastim Biosimilars
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2821&type=smp
What Are the Primary Drivers Shaping the Oncology Biosimilars Market?
The expiration of biologic patents in oncology is spurring the production of new oncology biosimilars. Biologics, which are targeted drugs derived from living organisms, offer similar efficacy to biosimilars, which are more cost-effective. The expiration of patents on several oncology biologics is expected to drive the development of new biosimilars in cancer care.
Which Companies Are Leading in the Oncology Biosimilars Market?
Major companies operating in the oncology biosimilars market include Biocon Biologics Limited, Celltrion Inc., Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer Inc., Apotex Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, BIOCAD, Amgen Inc., F. Hoffmann-La Roche, Sanofi SA, Mylan, Samsung Bioepis, Biogen International GmbH, Merck & Co. Inc., Coherus Biosciences, Eli Lilly and Company, Novartis AG, Viatris Inc., Accord Healthcare Ltd., Zydus Cadila Health Care Limited, Hetero Drugs Limited, Mundipharma International Limited, Mabion SA, Polpharma Biologics, Alvotech, Innovent Biologics, Gan & Lee Pharmaceuticals, Henlius Biotech
What Trends Are Expected to Dominate the Oncology Biosimilars Market in the Next 5 Years?
Pharmaceutical companies are ramping up investment in research and development to create new oncology biosimilars. They are capitalizing on the expanding biosimilars market by enhancing their R&D activities to support the creation and manufacturing of these new drugs. For example, in May 2022, Biocon Biologics, an India-based biopharmaceutical firm, and Viatris Inc., a US-based biosimilar manufacturer, introduced Abevmy (bevacizumab) in Canada. Abevmy is a biosimilar to Roche's Avastin (bevacizumab), a monoclonal antibody that targets VEGF to prevent the development of blood vessels necessary for tumor growth.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
What Are the Top Revenue-Generating Geographies in the Oncology Biosimilars Market?
The countries covered in the oncology biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Oncology Biosimilars Market?
2. What is the CAGR expected in the Oncology Biosimilars Market?
3. What Are the Key Innovations Transforming the Oncology Biosimilars Industry?
4. Which Region Is Leading the Oncology Biosimilars Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market Size Projected To Reach $16.48 Billion By 2034 With A Cagr Of 16.8% here
News-ID: 4058421 • Views: …
More Releases from The Business Research Company
Increasing Demand For Personal Care And Cosmetic Products Drives Coconut Oil Mar …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Coconut Oil Market Size By 2025?
In the last few years, the coconut oil market has experienced substantial growth. The market size is projected to rise from $5.03 billion in 2024 to $5.49 billion in 2025, which is an annual compound growth rate (CAGR) of 9.2%. This growth in the…
Driving Cloud Security Market Growth in 2025: The Role of Countering The Surge I …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Security Market Size Growth Forecast: What to Expect by 2025?
The size of the cloud security market has notably increased over the past few years. The market is projected to expand from a value of $17.11 billion in 2024 to reach $19.71 billion in 2025, representing a compound annual growth rate (CAGR) of…
Comprehensive Cloud Based Contact Center Market Forecast 2025-2034: Growth Trend …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Based Contact Center Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion in the cloud based contact center market has been substantial in the past few years. Its market size is projected to rise from $26.36 billion in 2024 to $31.04 billion in 2025, escalating at a compound…
Explosive Growth In The Consumer Electronics Fuels Circuit Protection Market: Po …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Circuit Protection Market Through 2025?
In recent times, the circuit protection market has experienced significant expansion. The market, which was valued at $54.5 billion in 2024, is projected to rise to $59.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
